Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by enriquesuaveon Apr 11, 2022 2:22pm
197 Views
Post# 34594447

RE:RE:RE:RE:RE:RE:RE:BTD Approval Request...???

RE:RE:RE:RE:RE:RE:RE:BTD Approval Request...???

Anyone know when Q4 end of year 2021 financials come out? If I remember usually end of April and Q1 is end of May.  I believe they told someone who called last November that they would release Quarterly at same time as financials. Next few weeks/months will hopefully have some nice developments and may we see BTD and our SP hit its $1.20 SP target.  


ScienceFirst wrote:

 

Yep!  That would be wise.  And that's fair to assume that this is what they're gonna do.  


For example, better to wait for the proper time (e.g. Breakthrough designation) to give more details about Rutherrin than too early as a Breakthrough designation would give us huge visibility.

You have to be strategic sometimes.

_________________

 

RE:RE:RE:RE:RE:BTD Approval Request...???
Fred, I can only hope they are holding those juicy PRs for after BTD approval, for Max impact...


<< Previous
Bullboard Posts
Next >>